Cervical Cancer Action - Strategies for HPV Vaccination in the Developing World

HPV vaccine represents an important opportunity to significantly reduce the global burden of cervical cancer. With more than 80% of cervical cancer cases affecting women in the developing world, the burden of this preventable disease disproportionately affects women in countries where cervical cancer screening and treatment systems are weak or non-existent. Developing strategies to effectively reach adolescent girls with HPV vaccines — a population not typically the focus of public health programs — is essential to achieving high coverage rates and reducing the cervical cancer burden. This brief outlines a number of newly identified strategies and best practices in community education, mobilization, and HPV vaccine delivery.

Cervical Cancer Action: A Global Coalition to Stop Cervical Cancer (CCA) was founded in 2007 to expedite the global availability, affordability, and accessibility of new and improved cervical cancer prevention technologies to women in developing countries.